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MEPROBAMATE INTOXICATION TREATED BY
PERITONEAL DIALYSIS:
Report of a case
W I L L I A M HARDY, M.D.,

ANDREW T E N PAS, M . D .

AND ROBERT K . N I X O N ,

M.D.*

MEMPROBAMATE (2 methyl-2-n-propyl 3-propanediol dicarbamate) has been used
extensively since 1955 in the treatment primarily of anxiety and tension states. The
mode of action is felt to be its ability to block selectively interneuronal circuits, reduce
exaggerated reflexes and muscle tension.
Not long after its initial use reports of untoward reactions and idiosyncrasy to
the drug appeared in the literature. The list has grown over the years.^"' After as little
as 200-400 mgm. of meprobamate, sensitive patients have experienced hypotension,
syncope, fever, urticaria, angioneurotic edema, erythematous rashes and non-thrombocytopenic purpura. Diarrhea, nausea, epigastric discomfort, excitement, nervousness,
arthralgias, diplopia, and temporary extra-ocular muscular paralysis have also been
reported. One death due to aplastic anemia followed the use of 400 mgm. of
meprobamate three times a day for 8 days.' In general, side-reactions have been
variously reported to occur in 2-17 per cent of patients treated.
As might be excepted, cases of overdosage and attempted suicide have occurred.
The case presented below demonstrates many of the findings typical of severe meprobamate intoxication with an unexpected and rapid recovery following the use of
peritoneal dialysis.
CASE REPORT

G. F., a 49 year old married tailor was brought to the Eraergency Room at approxiraately 10 a.ra., June 9, 1962, in a comatose state. History obtained from the patient's wife
revealed that he had ingested eighty 400 mgm. meprobamate tablets and seven 200 mgm
amobarbital and secobarbital capsules between 8 and 9 a.m. of the sarae raorning. The
patient was known to the hospital having been followed since 1958 for post-gastrectomy
weight loss and depression. He had recently been re-evaluated for his gastrointestinal coraplaints.
Physical exaraination revealed a thin elderly appearing white male in deep coma Blood
pressure was 70/50, pulse 100 and regular, respiration 24, regular and shallow. The patient
did not respond to painful stimuli, the pupils were dilated and reacted sluggishly to light.
Deep tendon reflexes were hypoactive and the plantar responses were flexor in character.
*Fifth Medical Division
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Emergency Roora treatment consisted of gastric lavage and the institution of intravenous fluids. With raaxiraal intravenous levartenerol, the blood pressure which subsequently fell to 50/40 was maintained at 80-100 systolic levels. Respirations, however,
became agonal in character and required endotracheal intubation with the use of a posidve
pressure respirator. Intravenous bemegride in 100 mgm. and 50 mgm. dosages had no appreciable affect.
A t 5:30 p.m. on the day of adraission peritoneal dialysis was instituted; introduction of
the catheter was perforraed without anesthesia and was bloodless. Over the next 24 hours
the patient was dialysed regularly in two hour cycles with a total of some 24,000 cc. of
Irapersol IV2 (Abbott). Potassiura chloride, tetracycline and heparin were added to the
dialysing fluid. During the sarae period the patient received 6,500 cc. of intravenous fluids
(5 per cent glucose in water and 5 per cent glucose in normal saline).
During the first five hours following institution of the peritoneal dialysis, the patient's
condition reraained essentially unchanged. A t 11 p.m. a slight cough reflex was noted with
endotracheal suction and at approximately 3:30 a.m. the following morning the patient's
reaction was such that the endotracheal tube had to be reraoved. A t this time there was
also noted to be a return of the deep tendon reflexes which were now hypoactive and equal.
The pupils became reactive and the patient responded to painful stirauli. By 4:30 a.m. of
the sarae morning, the patient was responding to questions and though still lethargic was
able to recognize his family. Blood pressure at this time was 100/80, pulse 110, respirations
26 and shallow. A t 6:30 a.m. the levophed was discontinued and the blood pressure reraained
stable. By 9:00 a.m. the patient was completely responsive and taking fluids by mouth.
Peritoneal dialysis was discontinued at 6:00 p.m. on June 10th at which time the
patient was able to sit in a chair and complained principally of weakness and numbness
of the left foot. Examination at that tirae revealed paresis of the dorsiflexors of the left
foot with decreased sensitivity to pinprick over the lower 1/3 of the left leg. This weakness
gradually iraproved during the patient's hospitalization but was still demonstrable at the
tirae of discharge ten days later. No further sequellae were noted.
DISCUSSION

Previous reports of the effects of meprobamate overdosage have all stressed
the degree of hypotension which is out of proportion to the respiratory depression,
the reverse of the situation seen w i t h barbiturate intoxication. Both hypotension and
respiratory depression were marked i n our case.
As has been noted, hypotension has been reported w i t h therapeutic doses of
meprobamate. Ingestion of 2.4 grams to 44 grams has resulted i n p r o f o u n d and
prolonged shock lasting up to 72 hours.'-'"" I t has been suggested that the marked
hypotension may be related to the effect on muscular tension; w i t h complete loss
of muscle tone, there is a lack of support to the vascular structures w i t h pooling of
blood and resulting hypotensive shock.
Five suicidal deaths due to meprobamate intoxication have been reported, w i t h
ingested amounts of 12-47.6 grams of the drug. These patients died f r o m cardiovascular collapse in periods ranging up to five days post-ingestion. Autopsies revealed
pulmonary congestion, bloody bronchial secretions and small pulmonary hemorrhages.'^-"-"
The majority of meprobamate intoxications have been treated symptomatically
w i t h support of blood pressure and respiration when needed. Methylphenidate* and
pentamethylentetraol** have been used w i t h survival of the patient."
*Ritalin (Ciba)
**Metrazol (KnoU)
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MEPROBA MA TE IN TOXIC A TION
With severe intoxication and resuhing profound hypotension which may prove
refractory to antihypotensive agents over a prolonged period, more aggressive treatment
would seem to be in order. To our knowledge, the present case of meprobamate
intoxication is the only reported one which has been treated by peritoneal dialysis.
Barbiturate, aspirin and methylalcohol intoxication have been treated successfully by
this technique.

It is generally conceded

that hemodialysis is the treatment of

choice for severe intoxications with dialyazble poisons.

However, this method is

cumbersome and not always available. Peritoneal dialysis represents a simple and
effective alternate choice.
Unfortunately, laboratory data to support the severity of the meprobamate intoxication of the present case is lacking.

Blood levels drawn on admission revealed

barbiturate level of 0.54 mgm per cent which is considerably below the level
considered clinically significant. Meprobamate levels could not be determined due to
technical difficulties.
Distribution and excretion studies of meprobamate

indicate that it is freely

diffusible and thus amenable to dialysis. Intraperitoneal injections of meprobamate
in laboratory animals have resulted in excellent absorption."
It is difficult to prove our contention that peritoneal dialysis was lifesaving in
the present case. However, the rapidity of change following its institution in a
patient as singularly and profoundly depressed as was our case, was most impressive
and would lead us to feel that peritoneal dialysis did have a decisive effect.
Of interest was the development of unilateral foot drop in our patient. This
complication of meprobamate poisoning has been previously reported, adding to the
list of unusual side effects of meprobamate that of neurologic involvement.

SUMMARY

A case of attempted suicidal poisoning with meprobamate is presented. Hypotension, respiratory and central nervous system depression with transient foot drop
characterized the clinical course. Initial treatment consisted of gastric lavage, support
of blood pressure and respiration. Peritoneal dialysis was instituted with the patient
in an agonal state, following which there was dramatic improvement over the
succeeding 12 hours to subsequent complete recovery.
The mode of action, side effects and toxicology of meprobamate
reviewed.
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